Solvotrin Therapeutics’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Solvotrin Therapeutics is a pharmaceutical company that develops and commercializes therapeutics for nutrition and vitamin deficiency. Read more

54 Followers on Owler
54 Followers on Owler
54 Followers on Owler
54 Followers on Owler

Solvotrin Therapeutics is a pharmaceutical company that develops and commercializes therapeutics for nutrition and vitamin deficiency. Read more

Pat O Flynn's photo - President & CEO of Solvotrin Therapeutics

President & CEO

Pat O Flynn

CEO Approval Rating

88/100

Founded:

2009

Status:

PrivateIndependent Company

Est. Annual Revenue
Est. Employees

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

ProSolus is one of Solvotrin Therapeutics's top rivals. ProSolus is a Private company that was founded in 2009 in Miami, Florida. Like Solvotrin Therapeutics, ProSolus also works within the Pharmaceuticals industry. Compared to Solvotrin Therapeutics, ProSolus has 10 more employees.

Cambrex is seen as one of Solvotrin Therapeutics's biggest rivals. Cambrex was founded in 1981 in East Rutherford, New Jersey. Like Solvotrin Therapeutics, Cambrex also competes in the Pharmaceuticals sector. Cambrex generates $575.5M more revenue than Solvotrin Therapeutics.

INNERCAP is one of Solvotrin Therapeutics's top competitors. INNERCAP was founded in 2003, and its headquarters is in Tampa, Florida. Like Solvotrin Therapeutics, INNERCAP also competes in the Pharmaceuticals space. INNERCAP has 10 fewer employees than Solvotrin Therapeutics.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Catalent a competitor of Solvotrin Therapeutics?

Acquisitions

No recent acquisitions found related to Solvotrin Therapeutics

Solvotrin Therapeutics Funding History

$2.1M$9.9M

Since Solvotrin Therapeutics was founded in 2009, it has participated in 2 rounds of funding. In total Solvotrin Therapeutics has raised $9.9M. Solvotrin Therapeutics' last funding round was on Nov 2020 for a total of $7.8M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Venture Round
Nov 2020
$7.8M

RAB Capital

Venture Round
Feb 2017
$2.1M

Since Solvotrin Therapeutics was founded in 2009, it has participated in 2 rounds of funding. In total Solvotrin Therapeutics has raised $9.9M. Solvotrin Therapeutics' last funding round was on Nov 2020 for a total of $7.8M

Investments

No recent investments found related to Solvotrin Therapeutics

Solvotrin Therapeutics News

November 2, 2020THE IRISH TIMES

Supplements group Solvotrin raises 6.7m to fund China, US expansion

Solvotrin Therapeutics, a Cork-based supplements group, has raised €6.7 million in funding from new a... See more »
October 30, 2019BizPlus

Solvotrin Poised For China Expansion

Developing academic research into a commercial product takes time and entrepreneurial expertise. Cork... See more »
June 14, 2019THE IRISH TIMES

Solvotrin agrees deal to supply China with drug for iron deficiency

Cork-based medicine development company Solvotrin Therapeutics has agreed a 20-year exclusive licensi... See more »
April 4, 2017THE IRISH TIMES

Cork-based firm set to shake up global iron supplements market

A groundbreaking iron product from Cork-based life sciences start-up Solvotrin Therapeutics looks set... See more »

Social Media

Headquarters

Hoffmann Park Little Island

Cork, County Cork

353-021-4510220

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Solvotrin Therapeutics is a pharmaceutical company that develops and commercializes therapeutics for nutrition and vitamin deficiency. Solvotrin Therapeutics was founded in 2009. Solvotrin Therapeutics' headquarters is located in Cork, County Cork, IE...

CEO

Solvotrin Therapeutics's President & CEO, Pat O Flynn, currently has an approval rating of 88%. Solvotrin Therapeutics's primary competitors are ProSolus, Cambrex & INNERCAP.

Website

solvotrin.com

Frequently Asked Questions about Solvotrin Therapeutics

  1. When was Solvotrin Therapeutics founded?

    Solvotrin Therapeutics was founded in 2009
  2. Who is Solvotrin Therapeutics's CEO?

    Solvotrin Therapeutics's CEO is Pat O Flynn
  3. How much revenue does Solvotrin Therapeutics generate?

    Solvotrin Therapeutics generates $43.7M in revenue
  4. How much funding does Solvotrin Therapeutics have?

    Solvotrin Therapeutics has historically raised $9.9M in funding
  1. Where is Solvotrin Therapeutics's headquarters?

    Solvotrin Therapeutics's headquarters is in Cork County Cork, IE
  2. How many employees does Solvotrin Therapeutics have?

    Solvotrin Therapeutics has 23 employees
  3. What sector does Solvotrin Therapeutics operate in?

    Solvotrin Therapeutics is in Pharmaceuticals
  4. Who are Solvotrin Therapeutics's competitors?

    Solvotrin Therapeutics's top competitors are ProSolus, Cambrex, INNERCAP